Sorrento Therapeutics Inc (SRNE)

Sector:
INFORMATION TECHNOLOGY
Industry:
SOFTWARE
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Henry H. Ji
Employees:
382
4955 DIRECTORS PLACE, SAN DIEGO, CA 92121
858-203-4100

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.

Data derived from most recent annual or quarterly report
Market Cap 544.313 Million Shares Outstanding342.335 Million Avg 30-day Volume 9.832 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.56
Price to Revenue39.2273 Debt to Equity0.8233 EBITDA-223.775 Million
Price to Book Value9.4976 Operating Margin-611.509 Enterprise Value1.347 Billion
Current Ratio0.894 EPS Growth0.447 Quick Ratio0.746
1 Yr BETA 2.0165 52-week High/Low 11.07 / 1.15 Profit Margin-786.3002
Operating Cash Flow Growth7.7805 Altman Z-Score-1.5388 Free Cash Flow to Firm -143.744 Million
Earnings Report2022-08-05
View SEC Filings from SRNE instead.

View recent insider trading info

Sorrento Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding SRNE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SRNE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CZEREPAK ELIZABETH EVP & CHIEF FINANCIAL OFFICER

  • Officer
 350,000 2022-05-18 3

REILLY TAMMY

  • Director
 0 2022-05-18 2

JANDA KIM

  • Director
 0 2021-12-27 4

JI HENRY SEE REMARKS

  • Officer
  • Director
 4,367,500 2021-09-29 2

SMITH ROBIN L

  • Director
 235,000 2021-09-03 2

SHAH JAISIM

  • Director
 250,000 2021-08-30 1

WU YUE ALEXANDER

  • Director
 250,000 2021-08-30 1

FOLLOWWILL DORMAN

  • Director
 250,000 2021-08-30 1

LEMUS DAVID

  • Director
 250,000 2021-08-30 1

ASGHAR NAJJAM CHIEF FINANCIAL OFFICER

  • Officer
 156,974 2021-03-16 0

LEE EDGAR

  • Director
 0 2020-06-15 0

SHAO JIONG CHIEF FINANCIAL OFFICER

  • Officer
 0 2020-06-15 0

ZELDIS JEROME B SEE REMARKS

  • Officer
 0 2018-11-26 0

ABG MANAGEMENT LTD

ABG II-SO LTD

ABG INNOVATION-SO LTD

ABG SRNE LTD

ALLY BRIDGE GROUP CAPITAL PARTNERS II, L.P.

ALLY BRIDGE GROUP INNOVATION CAPITAL PARTNERS III, L.P.

ALLY BRIDGE LB HEALTHCARE MASTER FUND LTD

ALLY BRIDGE LB MANAGEMENT LTD

LI BIN

YU FAN

  • 10% Owner
 No longer subject to file 2018-09-12 0

NG GEORGE K SEE REMARKS

  • Officer
 407,935 2018-02-28 0

FERRIGNO DEAN CHIEF ACCOUNTING OFFICER

  • Officer
 245 2018-02-28 0

ASIA PACIFIC MEDTECH (BVI) LTD

GU NANA

  • 10% Owner
 8,617,513 2018-01-23 0

DEMING DAVID H

  • Director
 0 2017-09-15 0

ABG MANAGEMENT LTD

ABG SRNE LTD

ALLY BRIDGE GROUP CAPITAL PARTNERS II, L.P.

ABG II-SO LTD

ALLY BRIDGE LB HEALTHCARE MASTER FUND LTD

ALLY BRIDGE LB MANAGEMENT LTD

ALLY BRIDGE GROUP INNOVATION CAPITAL PARTNERS III, L.P.

YU FAN

LI BIN

  • 10% Owner
 9,537,940 2017-04-19 0

SU JEFFREY EXECUTIVE VP AND COO

  • Officer
 13,000 2017-02-03 0

HERDE KEVIN EXECUTIVE VP AND CFO

  • Officer
 7,000 2017-02-03 0

TOLEDANO MIRANDA JAYNE EVP-CORPORATE DEVELOPMENT

  • Officer
 0 2016-09-16 0

EBERSOLE DOUGLAS O

  • Director
 0 2016-07-11 0

MARTH WILLIAM S

  • Director
 0 2016-07-11 0

SOON-SHIONG PATRICK

CHAN SOON-SHIONG FAMILY FOUNDATION

CAMBRIDGE EQUITIES, LP

MP 13 VENTURES, LLC

  • FORMER 10% OWNERFORMER 10% OWNERREPORTING GROUP MEMBERREPORTING GROUP MEMBER
 No longer subject to file 2016-07-07 0

SOON-SHIONG PATRICK

CAMBRIDGE EQUITIES, LP

CHAN SOON-SHIONG FAMILY FOUNDATION

  • 10% Owner
  • REPORTING GROUP MEMBER
8,061,999 2015-12-31 0

SOON-SHIONG PATRICK

MP 13 VENTURES, LLC

CAMBRIDGE EQUITIES, LP

  • 10% Owner
 8,061,999 2015-12-09 0

UY GEORGE SEE REMARKS

  • Officer
 201,735 2015-09-18 0

CHAN SOON-SHIONG FAMILY FOUNDATION

  • 10% Owner
 7,188,061 2015-07-24 0

MIAO ZHENWEI SVP, HEAD OF ADC DEVELOPMENT

  • Officer
 559,390 2015-05-21 0

DURAND MARK EVP & CFO

  • Officer
 0 2015-04-29 0

VINCENT RICHARD G SEE REMARKS

  • Officer
 0 2014-10-07 0

ROYAL MIKE SEE REMARKS

  • Officer
 0 2014-06-27 0

HALPRYN GLENN L

  • Director
 18,829,503 2011-04-15 0

HSIAO JANE PH D

  • Director
 2,231,719 2011-04-15 0

LOCKSHIN CURTIS

  • Director
 0 2011-04-15 0

AFTING ERNST-GUENTER

  • Director
 917,930 2010-12-21 0

ZANIBONI STEVE

  • Director
  • 10% Owner
 25,484,329 2010-11-29 0

SCHUH ANTONIUS CHAIRMAN AND CEO

  • Officer
  • Director
  • 10% Owner
 25,484,329 2010-02-16 0

MOLSBERGEN MARTINA VP, BUSINESS DEVELOPMENT

  • Officer
 0 2010-02-05 0

RODI CHARLES P VP, RESEARCH & DEVELOPMENT

  • Officer
 0 2010-02-05 0

OPKO HEALTH, INC.

  • 10% Owner
 59,015,257 2009-09-21 0

SHUSTER LEWIS

  • Director
 669,516 2009-09-21 0

FREEDMAN S. JAMES

  • Director
 111,586 2009-09-21 0

STEIN RONALD M

  • Director
 1,693,472 2008-07-07 0

KEATING KEVIN R

  • SEE REMARKS
 No longer subject to file 2008-07-07 0

WEISBERG ALAN JAY CFO

  • Officer
  • Director
 785,925 2008-07-07 0

GLAUSER STEVEN JERRY

  • 10% Owner
 41,086,194 2008-07-07 0

SILVER NOAH M VP, SECRETARY AND TREASURER

  • Officer
  • Director
 4,054,666 2008-07-07 0

KI EQUITY PARTNERS V LLC

  • SEE REMARKS
 No longer subject to file 2008-07-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

CZEREPAK ELIZABETH - Officer EVP & CHIEF FINANCIAL OFFICER

2022-05-20 17:14:46 -0400 2022-05-18 A 350,000 a 350,000 direct

REILLY TAMMY - Director

2022-05-20 17:11:29 -0400 2022-05-18 A 100,000 a 100,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 22:15:04 UTC -0.4637 1.2837 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 21:45:03 UTC -0.4626 1.2826 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 21:15:04 UTC -0.4626 1.2826 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 20:45:03 UTC -0.4652 1.2852 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 20:15:04 UTC -0.4652 1.2852 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 19:45:04 UTC -0.4652 1.2852 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 19:15:03 UTC -0.4652 1.2852 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 18:45:03 UTC -0.5418 1.3618 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 18:15:03 UTC -0.5418 1.3618 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 17:45:03 UTC -0.681 1.501 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 17:15:03 UTC -0.681 1.501 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 16:45:03 UTC -0.6796 1.4996 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 16:15:03 UTC -0.6796 1.4996 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 15:45:04 UTC -0.6796 1.4996 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 15:15:03 UTC -0.6796 1.4996 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 14:45:03 UTC -0.1758 0.9958 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 14:15:03 UTC -0.1758 0.9958 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 13:45:03 UTC -0.1758 0.9958 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 13:15:04 UTC -0.1758 0.9958 0
SORRENTO THERAPEUTICS INC SRNE 2022-05-23 12:45:03 UTC -0.1758 0.9958 0

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund SRNE -107200.0 shares, $-498480.0 2021-12-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- 361 Domestic Long/Short Equity Fund SRNE -3919.0 shares, $-13520.55 2022-01-31 N-PORT
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund SRNE -3058.0 shares, $-10550.1 2022-01-31 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund SRNE -518.0 shares, $-1206.94 2022-03-31 N-PORT

Elevate your investments